AQST vs XRAY · rev $28.3M vs rev $1.78B
Aquestive Therapeutics Inc (AQST) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
AQST currently screens at market cap $493.0M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the AQST and XRAY stock pages for the full models.
Not investment advice.